10 593

Cited 0 times in

韓國人에 있어서의 phenylephrine hydrochloride의 散瞳 作用

DC Field Value Language
dc.contributor.author김홍복-
dc.date.accessioned2015-11-22T07:03:44Z-
dc.date.available2015-11-22T07:03:44Z-
dc.date.issued1967-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/127009-
dc.description의학과/석사-
dc.description.abstract[한글] [영문] Introduction In 1910 Phenylephrine hydrochloride was introduced first by Barger and Dale. Phenylephrine hydrochloride is a synthetic sympathomimetic compound structurally similar to epinephrine and ephedrine. Synthetic phenylephrine hydrochloride is clinically used as a nasal decongestant, vasopressor and mydriatic, etc.. The use of phenylephrine hydrochloride in ophthalmological practice is based on its action of vasoconstriciton and mydriasis. Phenylephrine hydrochloride has been introduced in U.S.A. as 10% neosynephrine (U.S.P.) and in Japan as 5% neosynesine. It's usefulness in therapy and examination is due to the follow in characteristics; ;(1) Rapid effect, (2) No influence on intraocular pressure nor on accommodation, (3) No undesirable side reaction. In many countries including U.s.A. and Japan, they reported experimentally and clinically in detail about the mydriatic action of phenylephrine hydrochloride but unfortunately there is no data concerning mydriatic action of phenylephrine hydrochloride in Koreans in spite of its wide use in ophthalmology. The study was performed for dilatation of the pupil, influence on intraocoular pressure and accommodation, antagonistic action to pilocarpine, and side reaction after instillation of 10% neosynephrine (U.S.P.) by the following method. Method and Material Material; 10% Neosynephrine hydrochleride (U.S.P.) 2% Pilocarpine Subjects: 228 Korean normal eyes(6-84 yrs. old) Method; 1. Dilatation of the pupil (176 eyes) Group 1; One drop of 10% neosynephrine instilled into 75 eyes. Over 6o yrs. old………………10 eyes 36-59 yrs. old…………………17 eyes Under 35 yrs. old…………… 48 eyes Group 2; two drops of 10% neosynephrine instilled into 59 eyes. Over 60 yrs. old…………………2 eyes 36-59 yrs. old………………… 17 eyes Under 35 yrs. old………………40 eyes Group 3; three drope of 10% neosynephrine instilled into 42 eyes. Over 60 yrs. old…………………7 eyes 36-59 yrs. old………………… 14 eyes Under 35 yrs. old………………21 eyes Interval between each instillation was two or three minutes. After instillation of 10% neosynephrine into the eyes, the diameter of the pupils was measured frequently till maximum dilatation. 2. Influence on the intraocular pressure (25 eyes). After measurement of the intraocular pressure and diameter of the pupil in each eye, one drop of 10% neosynephrine was instilled into 9 eyes and two drops into 10 eyes, and three drops into 6 eyes. After that measurement of intraocular pressure and diameter of the pupil was done every 10 minutes for 90 minutes and 2 and 3 hrs. later. 3. Influence on acoommodation. The diameter of the pupil and distance of N.P.C. were measured before instillationof neosynephrine and every 10 minutes interval for 90 minutes and at 2 and 3 hrs. after instillation of 10% neosynephine into 23 eyes (oen drop into 8 eyes, two drops into 10 eyes, three drops into 5 eyes). 4. Antagonistic action of 2% pilocarpine to mydriatic action of 10% neosynephrine. In two eyes of a 26 yrs. old man, diameter of the pupil was measured and compared in both eyes before instillationof one drop of 10% neosynephrine and in 10 minutes interval to 90 minutes, at 2 and 3 hrs. after instillation of one drop of 10% neosynephrine into both eyes. Then one drop of 2% pilocarpine was instilled into only the right eye at 50 minutes after first instillationof neosynephrine. One drop of 10% neosynephrine was instilled into both eyes of a 23 yrs. old man. two drops into both eyes of a 20 yrs. old man, and three drops into both eyes of a man aged 22 yrs.. One drop of 2% pilocaripine was instilled into only the right eye of each person, respectively at 40 minutes (22 yrs. old eye), 50 minutes (20 yrs. old eye), and 60 minutes (23 yrs. old eye) after first instillation of neosynephrine. the diameter of the pupil, the distance of N.P.C., and the intraocular pressure were measured and compared in both eyes of each person before instillation and at 10 minutes intervals for 90 minutes, and at two and three hrs. after first instillation. Results and Conclusion 1. In most of 176 eyes, the diameter of the pupils reached more than 7.5mm (maximum dilatation) and they took an average of 42 minutes to reach their maximum dilatation. Among them, the shortest was 26 minutes and the longest 75 minutes. 2. the time the pupil takes to reach its maximum dilatation is a little differance between group 1(one drop of neosynephrine instilled) and group 2 (two drops of neosynephrine instilled) but definetely shorter in group 3 (three drops of neosynephrine instilled). 3. 10% neosynephrine has little influence on intraocular pressure. 4. 10% neosynephrine has slight influence on accommodation (slight paresis of accommodation) in about half of 26 eyes but they have no disturabance at near work (Table 2 and 3). 5. 2% pilocarpine constricts the dilated pupil more quickly than if not used (Table 4.). 6. Age has no effect on dilatation of the pupil due to instillation of 10% neosynephrine. 7. No undesirable side reaction was noted.-
dc.description.statementOfResponsibilityrestriction-
dc.publisher연세대학교 대학원-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title韓國人에 있어서의 phenylephrine hydrochloride의 散瞳 作用-
dc.title.alternativeMydriatic action of phenylephrine hydrochloride (10% neosynephrine) in Koreans.-
dc.typeThesis-
dc.contributor.departmentDept. of Ophthalmology (안과학교실)-
dc.contributor.localIdA01191-
dc.identifier.urlhttps://ymlib.yonsei.ac.kr/catalog/search/book-detail/?cid=CAT000000045157-
dc.contributor.alternativeNameKim, Hong Bok-
dc.contributor.affiliatedAuthor김홍복-
dc.type.localThesis-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 2. Thesis

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.